Is SARS-CoV-2 present in synovial joint fluid? [COVID-19]

  • Research type

    Research Study

  • Full title

    Is SARS-CoV-2 present in synovial joint fluid?

  • IRAS ID

    284296

  • Contact name

    Diane Back

  • Contact email

    diane.back@gstt.nhs.uk

  • Sponsor organisation

    Guy's and St Thomas' NHS Foundation Trust

  • Duration of Study in the UK

    0 years, 0 months, 29 days

  • Research summary

    As NHS organisations plan the return of elective orthopaedic surgery, protocols regarding the protection of medical and nursing staff are being formulated. \nAs GSTFT begins to plan the return to elective orthopaedic surgery, we are keen to investigate potential sources of exposure to the SARS-CoV-2. The bulk of orthopaedic work involves exposure to synovial joint fluid either through minimal incisions (eg arthroscopic work) or large open procedures (eg arthroplasty). Electrical power tools generate airborne particles, including synovial fluid.\n\nWe would like to analyse synovial joint fluid for the presence of SARS-CoV-2. Since late April 2020 GSTFT has been in a position to start doing hospital post-mortem examinations (autopsies) on COVID positive patients.\nThese samples will be collected by our consultant histopathologists in cases of deceased Covid positive patients who are already undergoing hospital consented post mortems. Samples shall be attempted from the knee and shoulder joints of each patient (a maximum of 4 samples). This will be done using an aseptic technique with a needle and syringe; no incisions or scars will be performed on the patients.\nThe samples will then be analysed in our hospital laboratory for the presence of SARS-CoV-2.

  • REC name

    North West - Greater Manchester East Research Ethics Committee

  • REC reference

    20/NW/0293

  • Date of REC Opinion

    16 Jun 2020

  • REC opinion

    Favourable Opinion